What is the porta hepatis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is the Porta Hepatis?

The porta hepatis is a transverse fissure on the inferior (visceral) surface of the liver where the major vascular and biliary structures enter and exit the organ, specifically comprising the portal vein, hepatic artery, and common bile duct (hepatic duct), along with lymphatics, nerves, and connective tissue 1.

Anatomical Components

The porta hepatis contains three primary structures that form the "portal triad":

  • Portal vein - typically positioned posteriorly in the porta hepatis
  • Hepatic artery - usually located anterior to the portal vein and medial to the bile duct
  • Common bile duct (CBD) - positioned anterior to the portal vein and lateral (to the left on imaging) relative to the hepatic artery 1

In a transverse imaging view, the CBD and hepatic artery are typically seen anterior to the portal vein, with the CBD more lateral 1.

Location and Dimensions

The porta hepatis is located on the visceral surface of the liver with specific anatomical relationships:

  • The center of the porta hepatis sits approximately 11.6 cm from the border of the visceral liver surface 2
  • It is positioned more posteriorly and slightly to the right on the inferior liver surface 3
  • The transverse diameter exceeds the anteroposterior diameter, making it slightly oval in the transverse plane 3

Clinical Significance

Imaging Identification

The porta hepatis can be located sonographically using several techniques 1:

  • Tracking the hepatic artery from the celiac axis
  • Following the portal vein from the confluence of splenic and superior mesenteric veins
  • Tracing portal vessels in the liver back to the hepatic hilum

The CBD can be distinguished from the hepatic artery by its absence of color-flow Doppler signal 1.

Pathological Considerations

A wide spectrum of diseases can affect the porta hepatis 4:

  • Vascular diseases: portal vein thrombosis, hepatic artery stenosis/thrombosis, aneurysms
  • Biliary diseases: choledochal cysts, cholangiocarcinoma, bile duct stones
  • Mass lesions: lymphadenopathy (neoplastic or inflammatory), neurogenic tumors, sarcomas
  • Portal vein thrombosis appears as numerous serpiginous vascular channels (cavernous transformation) when chronic 5

Surgical Importance

Understanding porta hepatis anatomy is critical for 3, 6:

  • Hepatobiliary surgeries including liver transplantation
  • Cholecystectomy procedures
  • Hepatoportoenterostomy in biliary atresia
  • Avoiding vascular and biliary injury during dissection

Anatomical Variations

Classical anatomy is present in only 20% of livers 3. The standard structural arrangement occurs in:

  • Hepatic artery: 59.1%
  • Portal vein: 55.5%
  • Hepatic duct: 51.8%

Based on structural distribution, 16 different anatomical types of porta hepatis have been described, with the hepatic artery showing the most variation, followed by the portal vein and hepatic duct 3.

Key Clinical Pitfall

Biliary ductules in the porta hepatis run in close relation to vascular structures and may be hidden between vessels, making them not always accessible during surgical dissection 6. This anatomical relationship is crucial for procedures like hepatoportoenterostomy, where securing intact biliary ductules from both lateral hepatic lobes is necessary for successful bile drainage 6.

References

2
Research

[The center of the human porta hepatis].

Medicina (Kaunas, Lithuania), 2008

4
Research

Imaging of the porta hepatis: spectrum of disease.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2014

6
Research

Anatomy of the porta hepatis (PH) as rational basis for the hepatoporto-enterostomy (HPE).

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 1999

Related Questions

What are porta hepatis masses?
What structures pass through the porta hepatis?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
Why would sotalol be indicated for a cancer patient receiving bevacizumab (Avastin) and trifluridine‑tipiracil (Lonsurf)?
Can amlodipine cause hyponatremia?
What are the DAWN criteria (age, NIH Stroke Scale score, and infarct core volume thresholds) for mechanical thrombectomy?
What does a urinalysis showing 11–30 white blood cells per high-power field and a urine culture with 25,000–50,000 colony‑forming units per milliliter of mixed urogenital flora indicate?
When and how should Glypressin (synthetic arginine vasopressin) be used, including dosing, for an adult with cirrhosis experiencing acute variceal hemorrhage or for postpartum hemorrhage?
What is the optimal fasting insulin range in healthy adults, and at what fasting insulin level or HOMA‑IR score is insulin resistance considered?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.